MRI of lower extremity impingement and friction syndromes in children

Although generally more common in adults, lower extremity impingement and friction syndromes are also observed in the pediatric age group. Encompassing femoroacetabular impingement, iliopsoas impingement, subspine impingement, and ischiofemoral impingement around the hip; patellar tendon–lateral femoral condyle friction syndrome; iliotibial band friction syndrome; and medial synovial plica syndrome in the knee as well as talocalcaneal impingement on the hindfoot, these syndromes frequently cause pain and may mimic other, and occasionally more ominous, conditions in children. Magnetic resonance imaging (MRI) plays a key role in the diagnosis of musculoskeletal impingement and friction syndromes. Iliopsoas, subspine, and ischiofemoral impingements have been recently described, while some features of femoroacetabular and talocalcaneal impingements have recently gained increased relevance in the pediatric population. Fellowship-trained pediatric radiologists and radiologists with imaging workloads of exclusively or overwhelmingly pediatric patients (particularly those without a structured musculoskeletal imaging program as part of their imaging training) specifically need to be aware of these rare syndromes that mostly have quite characteristic imaging findings. This review highlights MRI features of lower extremity impingement and friction syndromes in children and provides updated pertinent pathophysiologic and clinical data

A snapshot of teleradiology practice in Turkey: the results of a survey among radiologists

PURPOSEThis study featured a survey that offers a snapshot of various teleradiology practices in Turkey, a Group of Twenty country that has undertaken a major transformation of its health care system during the last two decades and is currently the world leader in terms of the combined number of per capita magnetic resonance imaging and computed tomography examinations performed (which represent the bulk of teleradiology services worldwide).METHODSThe study data was collected from 4736 Turkish Society of Radiology (TSR) members via an electronic platform in the web environment through a questionnaire consisting of 24 questions. The survey was conducted in a 3-month time window (March–May 2021). Statistical tools were used for the analysis of the quantitative data.RESULTSResponses from 156 members of the TSR comprised the study data, revealing that teleradiology is used for various applications in Turkey. Almost half of the participants (49%) performed teleradiology only in the private sector. Half of the respondents (51%) stated that they reported images at home for multiple centers. Moreover, 38% of the participants had been reporting more than 50 examinations per day, and 74% of the respondents earned less than 0.50 Euro per examination they reported. The overall satisfaction with teleradiology among the teleradiologists was, on average, 4.7 out of 10 points.CONCLUSIONThe results are both promising for the future (i.e., concerning the propensity for adopting new technology) and alarming for the current state of affairs (i.e., insufficient radiologist reimbursement and lack of licensing and accreditation of teleradiology service providers). Periodic surveys performed in countries with different health care systems concerning financial, technical, and medicolegal aspects might reveal an up-to-date landscape of teleradiology practices worldwide and help guide local and regional decision-makers

Fusariosis manifesting as targetoid purpuric cutaneous lesions in immunocompromised patients

[No abstract available

TSR guidelines for the practice of teleradiology: 2021 update*

This update of Turkish Society of Radiology’s (TSR) guidelines for the practice of teleradiology is intended to provide a reference framework for all parties involved in delivering imaging services away from the immediate vicinity of the patient. It includes relevant definitions and general principles, features organizational modes and qualifications of the practicing parties, lists technical issues, and addresses such management and legal aspects as archiving and documentation, security and privacy, reliability, responsibilities, quality inspection and improvement, reimbursement and accountability

Sacroiliac joint involvement in osteochondromatosis: identifying its prevalence and characteristics from cross-sectional imaging

PURPOSEApart from a few case reports, sacroiliac joint (SIJ) involvement in osteochondromatosis has not been studied. We aimed to determine the prevalence and characteristics of such involvement using cross-sectional imaging.METHODSIn this retrospective study, three observers (one junior radiologist and two musculoskeletal radiologists) independently reviewed computed tomography (CT) or magnetic resonance imaging (MRI) of patients in our database who had osteochondromatosis (≥2 osteochondromas across the skeleton) for SIJ involvement. The final decision was reached by the consensus of the two musculoskeletal radiologists in a later joint session.RESULTSOf the 36 patients with osteochondromatosis in our database, 22 (61%) had cross-sectional imaging covering SIJs (14 females, 8 males; age range 7–66 years; mean age 23 years; 13 MRI, 9 CT). Of these, 16 (73%) had intra-articular osteochondromas. For identifying SIJ osteochondromas on cross-sectional imaging, interobserver agreement was substantial [κ = 0.67; 95% confidence interval (CI): 0.34, 1.00] between the musculoskeletal radiologists and moderate (κ = 0.59; 95% CI: 0.23, 0.94) between the junior radiologist and the final consensus decision of the two musculoskeletal radiologists. In the cohort with cross-sectional imaging, the anatomical variations of the accessory SIJ (n = 6, 27%) and iliosacral complex (n = 2, 9%) were identified in six different patients with (n = 2) and without (n = 4) sacroiliac osteochondromas.CONCLUSIONCross-sectional imaging shows frequent (73%) SIJ involvement in osteochondromatosis, which, although a rare disorder, nevertheless needs to be considered in the differential diagnosis of such SIJ anatomical variants as the accessory SIJ and iliosacral complex. Differentiating these variants from osteochondromas is challenging in patients with osteochondromatosis

Investıgatıon of Protectıve Effects of Lıquıdambar Orıentalıs Extracts on Lıver Toxıcıty Induced By Carbon Tetrachlorıde

The aim of the study is to investigate if the extracts from Liquidambar orientalis (Sıgla Oil) have any protective effects on the liver after CCl4 exposure in rats. Our experimental study was based on of five groups of rats. Considering the loses during the experiments, each group was planned to use 10 rats (50 in total). The experiment was carried out by using Sprague-Dawley type, 3 or 4 months old rats. The first group were fed by standard rat food. The second group were given 0,8 ml/kg CCl4 intraperitoneally that dissolved in olive oil and the third group were given 8ml/kg CCl4 and 50 mg/kg extract of Liquidambar orientalis, the fourth group were given 0.8 ml/kg extract of Liquidambar orientalis, and the fifth group were given 8ml/kg CCl4 and 200 mg/kg extract of Liquidambar orientalis. CCl4 was given intraperitonally. The Liquidambar orientalis extracts were given intragastrically by gavage technique. On the 30th day of the experiment in accordance with the ethical rules, by taking heart blood and liver, kidney and brain tissue samples their ALT and AST, total protein, hemoglobin, oxidant (MDA, NO), antioxidant matter (GSH, GPx, CAT) levels were measured by spectroscopically methods. Histopathological examinations were examined and photographed in light microscope. According to the results, in the blood AST, ALT and MDA levels were significantly increased in all groups applied to CCl4 showed that damage. AST, ALT and MDA levels in treatment groups were observed to be decreased. Especially, a significant decrease was observed in the group treated with CCl4+200 mg/kg Liquidambar orientalis. GSH, GPx and CAT levels were observed a significant decreasing in all groups applied with CCl4 of the blood and tissues. While the levels of GSH and GPx were elevated in treatment groups, there was a decreasing in liver GPx. The CAT levels of CCl4+200 mg/kg Liquidambar orientalis group in brain and kidney were found to be close to the control group. NO levels in CCl4 groups were increased in all the tissues and blood compared to control groups. Especially NO levels in the kidney were too high. NO levels in all treatment groups were significantly decreased according to the CCl4 groups. These datas were shown that it will be usefull effects of sıgla oil in reducing of damage formed with result of CCl4 toxication in liver and other tissues.Bu çalışmamızda Liquidambar orientalis'ten elde edilen ekstrelerin (Sığla Yağı) ratlarda CCl4’e maruz bırakılmış karaciğeri koruyucu etkisinin olup olmadığı araştırılmıştır. Deneysel çalışmamız 5 gruptan oluşmuştur. Deney sırasında olası kayıplar da göz önüne alındığında her grup için 10 adet olmak üzere toplam 50 adet rat kullanılmıştır. Çalışma Sprague-Dawley cinsi 3–4 aylık erkek sıçanlarda yapılmıştır. 1.grup, standart yemle beslenmiştir, 2.gruba, zeytinyağında çözdürülmüş 0,8 ml/kg CCl4, 3.gruba, 0,8 ml/kg CCl4 ve 50 mg/kg Liquidambar orientalis ekstresi, 4.gruba, 0,8 ml/kg CCl4 ve 100 mg/kg Liquidambar orientalis ekstresi, 5.gruba, 0,8 ml/kg CCl4 ve 200 mg/kg Liquidambar orientalis ekstresi verilmiştir. CCl4 intraperitoneal olarak uygulanmıştır. Liquidambar orientalis ekstreleri gavaj yöntemiyle intragastrik olarak verilmiştir. Çalışmanın 30. gününde hayvanlardan etik kurallara uygun olarak kalp kanı, karaciğer, beyin ve böbrek doku örnekleri alınarak ALT, AST, total protein, hemoglobin düzeyleri, oksidan (MDA, NO), antioksidan (GSH, GPx, CAT) düzeyleri spektroskopik yöntemlerle ölçülmüştür. Histopatolojik incelemeler ışık mikroskobunda incelenmiş ve fotoğraflanmıştır. Elde edilen sonuçlara göre, kanda AST ve ALT, MDA düzeylerinin CCl4 uygulanan tüm gruplarda belirgin derecede artması hasarın oluştuğunu göstermiştir. Tedavi gruplarında AST, ALT ve MDA seviyelerinin düştüğü gözlenmiştir. Özellikle CCl4+200 mg/kg Liquidambar orientalis uygulanan grupta önemli oranda düşüş gözlenmiştir. GSH, GPx ve CAT seviyeleri, tüm kan ve dokuların CCl4 uygulanan gruplarında anlamlı bir şekilde düşmüştür. Tedavi gruplarında GSH ve GPx seviyesi yükselmişken, karaciğerde GPx’de düşme gözlenmiştir. Beyin ve böbrekteki CCl4+200 mg/kg Liquidambar orientalis’teki CAT düzeylerinin kontrol grubuna yakın olduğu görülmüştür. CCl4 gruplarındaki NO seviyeleri, kontrol gruplarına göre kan ve tüm dokularda yükselmiştir. Özellikle böbrekteki NO seviyesi çok yüksek bulunmuştur. Tedavi gruplarının tümünde NO seviyesinin CCl4 gruplarına göre anlamlı bir şekilde azaldığı görülmüştür. Bu bulgular CCl4 toksikasyonu sonucunda karaciğer ve diğer dokularda oluşan hasarın azaltılmasında sığla yağının (özellikle 200 mg/kg dozu) yararlı etkilerinin olabileceğini göstermektedir

Hidden Healing Potion Of The Aegean: Sığla

Endemik bir bitki türü olan Sığla (Günlük Ağacı, Liquidambar orientalis) Muğla ilimize bağlı Marmaris, Fethiye, Köyceğiz ve Ula ilçelerinde yetişmektedir. Günlük ağacından elde edilen sığla yağı iyi bir antiseptik ve parazit öldürücüdür. Pomat ve yakı halinde uyuz ve mantar gibi cilt hastalıklarında yararlıdır. Mide hastalıklarının tedavisinde, astım bronşit gibi solunum yolu rahatsızlıklarında da kullanılmaktadır. Sığla yağı ekonomik açıdan da çok önemlidir: fiksatör olarak parfümeride, kozmetikte, sabunların kokulandırılmasında, eczacılıkta bazı ilaçların hazırlanmasında, ciklet ve tütünlerin kokulandırılmasında, ayrıca sinnamik asit, sinnamik alkol gibi kimyasal maddelerin doğal kaynağı olarak kullanılmaktadır. Sığla yağından su buharı destilasyonu ile elde edilen nötral uçucu yağ da pek çok değerli doğal esanslı parfümün bileşimine girmektedir.Sinnamik asit içeren sığla yağının yapılan çalışmalarla antioksidan özelliği ortaya konmuştur.Bu çalışmamızda sığla yağının sağlığa faydaları, ekonomik açıdan faydalanımı ve tanıtımı amaçlanmıştır.Sıgla (Günlük tree, Liquidambar orientalis ) which is an endemic plant species is grown in the districts of Fethiye, Ula, Köyceğiz of Muğla city.Sığla oil obtained from Günlük tree is a good antiseptic and antiparasitic. It is useful in skin diseases like scabies and fungal. İt is also used in the treatment of gastric diseases, respiratory diseases such as asthma and bronchitis.Sığla oil is very important economically. İ t is used as fixators in perfumery, in cosmetics, in the odour of soaps, in the preparation of some drugs, in the flavored of chewing gum and tobacco, also it is used as natural sources of chemicals such as cinnamic acids and cinnamic alcohol. Neutral essential oil which is obtained from sığla oil by steam distillation is entered to the composition of many valuable natural scents of perfume. Antioxidant properties of sığla oil that is contained cinnamic acid have been revealed by scientific studies. Health benefits, economically usage and promotion of sığla oil is intended in this study